Vanda Pharmaceuticals Inc. (LON:0LKB)
London
· Delayed Price · Currency is GBP · Price in USD 4.400
-0.120 (-2.65%)
At close: Feb 21, 2025
Vanda Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 102.32 | 135.82 | 135.03 | 52.07 | 61.03 | Upgrade
|
| Short-Term Investments | 272.33 | 252.44 | 331.83 | 380.74 | 306.71 | Upgrade
|
| Cash & Short-Term Investments | 374.64 | 388.26 | 466.86 | 432.81 | 367.74 | Upgrade
|
| Cash Growth | -3.51% | -16.83% | 7.87% | 17.70% | 17.82% | Upgrade
|
| Receivables | 47.1 | 34.16 | 33.51 | 32.47 | 30.04 | Upgrade
|
| Inventory | 1.73 | 1.36 | 1.19 | 1.03 | 1.28 | Upgrade
|
| Prepaid Expenses | 15.42 | 9.17 | 6.23 | 12 | 10.03 | Upgrade
|
| Restricted Cash | - | - | - | - | 0.06 | Upgrade
|
| Other Current Assets | - | - | 11.5 | - | - | Upgrade
|
| Total Current Assets | 438.89 | 432.95 | 519.29 | 478.3 | 409.15 | Upgrade
|
| Property, Plant & Equipment | 12.68 | 9.14 | 10.97 | 12.39 | 14.6 | Upgrade
|
| Other Intangible Assets | 114.1 | 121.37 | 18.57 | 20.08 | 21.56 | Upgrade
|
| Long-Term Deferred Tax Assets | 81.44 | 75 | 74.04 | 74.88 | 81.52 | Upgrade
|
| Other Long-Term Assets | 9.1 | 9.99 | 11.38 | 8.15 | 6.64 | Upgrade
|
| Total Assets | 656.2 | 648.44 | 634.25 | 593.79 | 533.46 | Upgrade
|
| Accounts Payable | 3.5 | 7.15 | 12.69 | 0.93 | 1.05 | Upgrade
|
| Accrued Expenses | 31.32 | 28.92 | 30.53 | 31.2 | 27.99 | Upgrade
|
| Current Portion of Leases | 4.27 | 2.4 | 2.33 | 2.31 | 2.12 | Upgrade
|
| Other Current Liabilities | 60.9 | 49.24 | 45.89 | 39.98 | 34.78 | Upgrade
|
| Total Current Liabilities | 99.98 | 87.7 | 91.44 | 74.42 | 65.94 | Upgrade
|
| Long-Term Leases | 8.09 | 7.01 | 8.81 | 10.06 | 11.5 | Upgrade
|
| Other Long-Term Liabilities | 9.59 | 8.83 | 6.8 | 4.39 | 2.76 | Upgrade
|
| Total Liabilities | 117.66 | 103.53 | 107.05 | 88.86 | 80.19 | Upgrade
|
| Common Stock | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | Upgrade
|
| Additional Paid-In Capital | 712.71 | 700.27 | 686.24 | 669.22 | 650.3 | Upgrade
|
| Retained Earnings | -174.29 | -155.39 | -157.9 | -164.18 | -197.33 | Upgrade
|
| Comprehensive Income & Other | 0.07 | -0.03 | -1.19 | -0.18 | 0.24 | Upgrade
|
| Shareholders' Equity | 538.55 | 544.91 | 527.2 | 504.93 | 453.27 | Upgrade
|
| Total Liabilities & Equity | 656.2 | 648.44 | 634.25 | 593.79 | 533.46 | Upgrade
|
| Total Debt | 12.36 | 9.4 | 11.14 | 12.37 | 13.61 | Upgrade
|
| Net Cash (Debt) | 362.28 | 378.86 | 455.72 | 420.45 | 354.13 | Upgrade
|
| Net Cash Growth | -4.38% | -16.87% | 8.39% | 18.73% | 19.02% | Upgrade
|
| Net Cash Per Share | 6.23 | 6.58 | 8.00 | 7.39 | 6.42 | Upgrade
|
| Filing Date Shares Outstanding | 58.32 | 57.54 | 56.79 | 55.91 | 54.88 | Upgrade
|
| Total Common Shares Outstanding | 58.31 | 57.53 | 56.78 | 55.9 | 54.87 | Upgrade
|
| Working Capital | 338.91 | 345.25 | 427.86 | 403.88 | 343.21 | Upgrade
|
| Book Value Per Share | 9.24 | 9.47 | 9.28 | 9.03 | 8.26 | Upgrade
|
| Tangible Book Value | 424.45 | 423.54 | 508.63 | 484.85 | 431.71 | Upgrade
|
| Tangible Book Value Per Share | 7.28 | 7.36 | 8.96 | 8.67 | 7.87 | Upgrade
|
| Machinery | 8.23 | 7.78 | 7.58 | 7.03 | 6.71 | Upgrade
|
| Leasehold Improvements | 5.47 | 5.44 | 5.42 | 5.46 | 5.46 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.